Inventor · disambiguated record
Yoshiyuki Taoda
Also filed as: TAODA YOSHIYUKI
31 granted patents·26 pending applications·408 citations·filing 2004–2024
97Inventor score
Files withSHIONOGI & CO41JOHNS BRIAN ALVIN4YOSHIDA HIROSHI3PURDUE PHARMA LP2UNIV HOKKAIDO NAT UNIV CORP2
Top patents by PatentIndex Score
57 records- 0198US8778943B2Substituted 10-hydroxy-9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1h-pyrido[1,2-α]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazine-8-carboxamidesSHIONOGI & CO·Filed 2013·Granted Jul 15, 2014·30 cites·4 claims
- 0298US8129385B2Substituted 5-hydroxy-3,4,6,9,9a, 10-hexanhydro-2h-1-oxa04a,8a-diaza-anthracene-6,10-dionessJOHNS BRIAN ALVIN·Filed 2006·Granted Mar 6, 2012·66 cites·11 claims
- 0397US9051337B2Substituted 10-hydroxy-9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1h-pyrido[1,2-a]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazine-8-carboxamidesSHIONOGI & CO·Filed 2014·Granted Jun 9, 2015·27 cites·7 claims
- 0497US8410103B2(3S,11aR)-N-[2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide useful as anti-HIV agentJOHNS BRIAN ALVIN·Filed 2012·Granted Apr 2, 2013·33 cites·7 claims
- 0597US8188271B2Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activityYOSHIDA HIROSHI·Filed 2006·Granted May 29, 2012·43 cites·14 claims
- 0695US11492352B2Arenavirus growth inhibitor comprising polycyclic carbamoylpyridone derivativeUNIV HOKKAIDO NAT UNIV CORP·Filed 2019·Granted Nov 8, 2022·9 cites·24 claims
- 0795US9815835B2Substituted polycyclic carbamolypyridone derivativeSHIONOGI & CO·Filed 2016·Granted Nov 14, 2017·11 cites·12 claims
- 0895US8624023B2Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediatesYOSHIDA HIROSHI·Filed 2009·Granted Jan 7, 2014·15 cites·11 claims
- 0995US7858788B2Bicyclic carbamoylpyridone derivative having HIV integrase inhibitory activitySHIONOGI & CO·Filed 2006·Granted Dec 28, 2010·47 cites·3 claims
- 1094US11267823B2Substituted 1,2,3,3a,4,5,7,9,13,13a-decahydropyrido[1′,2′:4,5]pyrazino[1,2-a]pyrrolo[1,2-c]pyrimidines having HIV integrase inhibitory activitySHIONOGI & CO·Filed 2020·Granted Mar 8, 2022·2 cites·10 claims
- 1194US10927129B2N-[(2,4-difluorophenyl)methyl]-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3] oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide having HIV integrase inhibitory activitySHIONOGI & CO·Filed 2019·Granted Feb 23, 2021·3 cites·12 claims
- 1293US9273065B2Substituted pyrido[1',2':4,5]pyrazino[1,2-a]pyrimidines as HIV integrase inhibitorsSHIONOGI & CO·Filed 2015·Granted Mar 1, 2016·3 cites·8 claims
- 1393US8987441B2Substituted polycyclic carbamoyl pyridone derivative prodrugTAKAHASHI CHIKA·Filed 2011·Granted Mar 24, 2015·44 cites·32 claims
- 1492US9469638B2Substituted polycyclic carbamoylpyridone derivativeSHIONOGI & CO·Filed 2014·Granted Oct 18, 2016·9 cites·8 claims
- 1592US2024279238A1Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activitySHIONOGI & CO·Filed 2024·Application pending·0 cites
- 1690US8927710B2Substituted polycyclic carbamoylpyridone derivativeAKIYAMA TOSHIYUKI·Filed 2010·Granted Jan 6, 2015·18 cites·23 claims
- 1789US11814368B2Triazine derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the sameSHIONOGI & CO·Filed 2022·Granted Nov 14, 2023·3 cites·15 claims
- 1889US9758515B2Substituted polycyclic carbamoyl pyridone derivative prodrugSHIONOGI & CO·Filed 2014·Granted Sep 12, 2017·13 cites·14 claims
- 1985US10202379B2Substituted polycyclic carbamoyl pyridone derivative prodrugSHIONOGI & CO·Filed 2017·Granted Feb 12, 2019·4 cites·17 claims
- 2084US9278967B2Substituted-quinoxaline-type piperidine compounds and the uses thereofPURDUE PHARMA LP·Filed 2014·Granted Mar 8, 2016·6 cites·20 claims
- 2183US2022213121A1SUBSTITUTED 1,2,3,3a,4,5,7,9,13,13a-DECAHYDROPYRIDO[1',2':4,5]PYRAZINO[1,2-a]PYRROLO[1,2-c]PYRIMIDINES HAVING HIV INTEGRASE INHIBITORY ACTIVITYSHIONOGI & CO·Filed 2022·Application pending·0 cites
- 2283US2024182463A1Substituted polycyclic carbamoyl pyridone derivative prodrugSHIONOGI & CO·Filed 2023·Application pending·0 cites
- 2382US8846929B2Substituted-quinoxaline-type piperidine compounds and the uses thereofFUCHINO KOUKI·Filed 2010·Granted Sep 30, 2014·9 cites·111 claims
- 2481US9527840B2Substituted-quinoxaline-type piperidine compounds and the uses thereofPURDUE PHARMA LP·Filed 2016·Granted Dec 27, 2016·3 cites·20 claims
- 2579US11453669B2Polycyclic pyridone derivativeSHIONOGI & CO·Filed 2019·Granted Sep 27, 2022·2 cites·18 claims
- 2679US2019152990A1Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activitySHIONOGI & CO·Filed 2019·Application pending·0 cites
- 2777US12139489B2Polycyclic carbamoylpyridone derivativeSHIONOGI & CO·Filed 2023·Granted Nov 12, 2024·0 cites·10 claims
- 2876US8575197B2Pyrolinone derivative and pharmaceutical composition comprising the sameKAI HIROYUKI·Filed 2009·Granted Nov 5, 2013·4 cites·3 claims
- 2976US2024352015A1Polycyclic carbamoylpyridone derivativeSHIONOGI & CO·Filed 2024·Application pending·0 cites
- 3074US2017369509A1Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activitySHIONOGI & CO·Filed 2017·Application pending·0 cites
- 3173US2017260203A1Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activitySHIONOGI & CO·Filed 2017·Application pending·0 cites
- 3273US2017267693A1Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activitySHIONOGI & CO·Filed 2017·Application pending·0 cites
- 3373US2017145033A1Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activitySHIONOGI & CO·Filed 2017·Application pending·0 cites
- 3473US2017224694A1Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activitySHIONOGI & CO·Filed 2017·Application pending·0 cites
- 3573US2017224695A1Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activitySHIONOGI & CO·Filed 2017·Application pending·0 cites
- 3673US2017209454A1Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activitySHIONOGI & CO·Filed 2017·Application pending·0 cites
- 3773US2017253616A1Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activitySHIONOGI & CO·Filed 2017·Application pending·0 cites
- 3872US2017029438A1Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activitySHIONOGI & CO·Filed 2016·Application pending·0 cites
- 3971US12098151B2Arenavirus growth inhibitor comprising polycyclic carbamoyl pyridone derivativeUNIV HOKKAIDO NAT UNIV CORP·Filed 2022·Granted Sep 24, 2024·0 cites·8 claims
- 4071US2016304535A1Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activitySHIONOGI & CO·Filed 2016·Application pending·0 cites
- 4171US2020339565A1Prodrug substituted polycyclic carbamoyl pyridone derivativeSHIONOGI & CO·Filed 2019·Application pending·0 cites
- 4270US2016137666A1SUBSTITUTED CYCLOPENTA[4,5]OXAZOLO[3,2-a]PYRIDO[1,2-d]PYRAZINES AS HIV INTEGRASE INHIBITORSSHIONOGI & CO·Filed 2016·Application pending·0 cites
- 4370US2016207939A1Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activitySHIONOGI & CO·Filed 2016·Application pending·0 cites
- 4467US8183372B2Substituted 9,11-dioxo-2,3,4a,5,9,11,13,13a-octahydor-1H-pyrido[1,2-a]pyrrolo[1′,2′:3,4]imidazo[1,2-d]pyrazinesJOHNS BRIAN ALVIN·Filed 2009·Granted May 22, 2012·0 cites·1 claims
- 4566US8754214B2Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediatesSHIONOGI & CO·Filed 2013·Granted Jun 17, 2014·0 cites·2 claims
- 4665US11649236B2Polycyclic carbamoylpyridone derivativeSHIONOGI & CO·Filed 2019·Granted May 16, 2023·0 cites·20 claims
- 4765US7745453B2Hydroxypyrimidinone derivatives having inhibitory activity against HIV integraseSHIONOGI & CO·Filed 2004·Granted Jun 29, 2010·4 cites·12 claims
- 4864US2019248785A1Substituted polycyclic carbamoyl pyridone derivative prodrugSHIONOGI & CO·Filed 2018·Application pending·0 cites
- 4963US9365587B2Synthesis of carbamoylpyridone HIV integrase inhibitors and intermediatesSHIONOGI & CO·Filed 2015·Granted Jun 14, 2016·0 cites·17 claims
- 5058US8691823B2Prodrugs of (4aS, 13ar)-N-[(2,4-difluorophenyl)methyl]-10-hydroxy-9-11-dioxo-2,3,4a,5,9,11,13,13a-octahydro-1H-pyrido[1,2-a]pyrrolo[1′,2′:3:4]imidazo[1,2-d]pyrazine-8-carboxamide and their use in the treatment of HIV infectionSHIONOGI & CO·Filed 2013·Granted Apr 8, 2014·0 cites·10 claims
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yoshiyuki Taoda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →